1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Chile >
  5. Abbott Acquires CFR Pharmaceuticals S.A.

M&A Deal Summary

Abbott Acquires CFR Pharmaceuticals S.A.

On May 16, 2014, Abbott acquired life science company CFR Pharmaceuticals S.A. for 2.9B USD

Acquisition Highlights
  • This is Abbott’s 10th transaction in the Life Science sector.
  • This is Abbott’s 9th largest (disclosed) transaction.
  • This is Abbott’s 1st transaction in Chile.

M&A Deal Summary
Date 2014-05-16
Target CFR Pharmaceuticals S.A.
Sector Life Science
Buyer(s) Abbott
Deal Type Add-on Acquisition
Deal Value 2.9B USD

Target

CFR Pharmaceuticals S.A.

Providencia,, Chile
CFR Pharmaceuticals S.A. is engaged in the research, development, production, and sale of specialty generic medicines and complex injectables.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Abbott

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 42.0B USD (2024)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott is a diversified, global provider of diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott was founded in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 25 of 36
Sector: Life Science M&A 10 of 12
Type: Add-on Acquisition M&A Deals 25 of 36
Country: Chile M&A 1 of 1
Year: 2014 M&A 1 of 3
Size (of disclosed) 9 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-19 OptiMedica

Santa Clara, California, United States

OptiMedica Corp. is an ophthalmic device company.

Buy $250M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-06-23 Veropharm

Moscow, Russia

Veropharm is a Russian pharmaceutical producer known in Russia and abroad as one of Russia’s major manufacturers of generic drugs that are identical to their brand name counterparts, oncological medications, and medical adhesive bandages.

Buy $305M
Mergr

Solution for

Product

Company

Legal